Clinical Trial Update: A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

View source ↗

Summary

A clinical trial update on Asciminib for Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Germany, focusing on tolerability, safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Leukemia, Chronic Myeloid | Status: NOT_YET_RECRUITING